Sales & Marketing News | pharmaphorum

News

US and UK flags side by side blending into each other

UK and US agree zero tariffs on pharma – with price rises

A deal between the UK and the US will maintain tariffs on imports into the US at 0%, but prices of medicines used by the NHS will go up.

News

EMA starts review of 'transformative' bladder cancer therapy

The EMA has started a review of a regimen based on Pfizer/Astellas' Padcev and MSD's Keytruda that is described as a game-changer for bladder cancer.

News

Is FDA about to restrict vaccination even further?

Vinay Prasad, head of CBER, is reported to be planning to tighten regulations on vaccines after concluding that COVID-19 shots caused 10 child deaths.

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

Tonix launches its new fibromyalgia drug in US

Tonix has launched its fibromyalgia therapy Tonmya in the US, the first new drug for the painful condition in more than 16 years.

News

Graphic of man flying a white flag against a teal background

Lundbeck bows out of bidding war for Avadel

Lundbeck won't raise its offer to buy Avadel any further, clearing the way for the sleep disorder specialist to complete a merger with Alkermes.

UK and US agree zero tariffs on pharma – with price rises

EMA starts review of 'transformative' bladder cancer therapy

Is FDA about to restrict vaccination even further?

Innovent gets OK for China's first home-grown IL-23p19 drug

Tonix launches its new fibromyalgia drug in US

Lundbeck bows out of bidding war for Avadel

MSD gets first FDA okay for oral PCSK9 cholesterol drug

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks